Skip to content

Emerald Health Therapeutics Inc.

CIK 0001768225

← back to feed
Revenue (TTM)
17.72M
+958.5% YoY FY Dec 2019
Net Income (TTM)
−27.99M
−261.2% YoY FY Dec 2019
EPS Diluted (TTM)
—
FY Dec 2019
Gross Margin
-45.2%
FY Dec 2019
Operating Margin
-275.8%
FY Dec 2019
Net Margin
-158.0%
FY Dec 2019
Free Cash Flow (TTM)
—
FY Dec 2019
Cash
2.53M
FY Dec 2019
Total Debt
—
FY Dec 2019
Shares Outstanding
160.99M sh
FY Dec 2019

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings